BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2390 related articles for article (PubMed ID: 33781348)

  • 1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    Syst Rev; 2021 Mar; 10(1):89. PubMed ID: 33781348
    [No Abstract]   [Full Text] [Related]  

  • 2. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    Rev Esp Cardiol (Engl Ed); 2021 Sep; 74(9):790-799. PubMed ID: 34446261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    Int J Surg; 2021 Apr; 88():105906. PubMed ID: 33789826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration.
    Welch V; Petticrew M; Petkovic J; Moher D; Waters E; White H; Tugwell P;
    J Clin Epidemiol; 2016 Feb; 70():68-89. PubMed ID: 26348799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    BMJ; 2009 Jul; 339():b2700. PubMed ID: 19622552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    Ann Intern Med; 2009 Aug; 151(4):W65-94. PubMed ID: 19622512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    PLoS Med; 2021 Mar; 18(3):e1003583. PubMed ID: 33780438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review.
    Page MJ; Moher D
    Syst Rev; 2017 Dec; 6(1):263. PubMed ID: 29258593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endorsement of PRISMA statement and quality of systematic reviews and meta-analyses published in nursing journals: a cross-sectional study.
    Tam WW; Lo KK; Khalechelvam P
    BMJ Open; 2017 Feb; 7(2):e013905. PubMed ID: 28174224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of study quality with completeness of reporting: have completeness of reporting and quality of systematic reviews and meta-analyses in major radiology journals changed since publication of the PRISMA statement?
    Tunis AS; McInnes MD; Hanna R; Esmail K
    Radiology; 2013 Nov; 269(2):413-26. PubMed ID: 23824992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    J Clin Epidemiol; 2021 Jun; 134():178-189. PubMed ID: 33789819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Moher D
    J Clin Epidemiol; 2021 Jun; 134():103-112. PubMed ID: 33577987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PRISMA statement: a guideline for systematic reviews and meta-analyses.
    Swartz MK
    J Pediatr Health Care; 2011; 25(1):1-2. PubMed ID: 21147401
    [No Abstract]   [Full Text] [Related]  

  • 15. From QUOROM to PRISMA: a survey of high-impact medical journals' instructions to authors and a review of systematic reviews in anesthesia literature.
    Tao KM; Li XQ; Zhou QH; Moher D; Ling CQ; Yu WF
    PLoS One; 2011; 6(11):e27611. PubMed ID: 22110690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Introduction to PRISMA-CI extension statement and checklist systematic reviews on complex interventions].
    Zhang G; Wang WW; Yang ZR; Zhan SY; Sun F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jul; 40(7):832-838. PubMed ID: 31357807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRISMA 2020 statement: What's new and the importance of reporting guidelines.
    Sohrabi C; Franchi T; Mathew G; Kerwan A; Nicola M; Griffin M; Agha M; Agha R
    Int J Surg; 2021 Apr; 88():105918. PubMed ID: 33789825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AHRQ series on complex intervention systematic reviews-paper 6: PRISMA-CI extension statement and checklist.
    Guise JM; Butler ME; Chang C; Viswanathan M; Pigott T; Tugwell P;
    J Clin Epidemiol; 2017 Oct; 90():43-50. PubMed ID: 28720516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PRISMA 2020 statement in Portuguese: updated recommendations for reporting systematic reviews.
    Galvão TF; Tiguman GMB; Sarkis-Onofre R
    Epidemiol Serv Saude; 2022; 31(2):e2022364. PubMed ID: 35894393
    [No Abstract]   [Full Text] [Related]  

  • 20. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
    Page MJ; McKenzie JE; Bossuyt PM; Boutron I; Hoffmann TC; Mulrow CD; Shamseer L; Tetzlaff JM; Akl EA; Brennan SE; Chou R; Glanville J; Grimshaw JM; Hróbjartsson A; Lalu MM; Li T; Loder EW; Mayo-Wilson E; McDonald S; McGuinness LA; Stewart LA; Thomas J; Tricco AC; Welch VA; Whiting P; Moher D
    BMJ; 2021 Mar; 372():n71. PubMed ID: 33782057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 120.